Onyx Biotec (NSE:ONYX) Asset Turnover: 0.37 (As of Mar. 2026)


NSE:ONYX Onyx Biotec Ltd NSE:ONYX
13 GF Score
Price ₹41.50
! 6 Warning Signs
View Full Analysis

What is Onyx Biotec Asset Turnover?

Onyx Biotec NSE:ONYX -0.36% 13 Asset Turnover is 0.37 as of Mar. 2026. GuruFocus rates NSE:ONYX with a GF Score™ of 13/100. The stock has 6 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Onyx Biotec's Revenue for the six months ended in Mar. 2026 was ₹348.8 Mil. Onyx Biotec's Total Assets for the quarter that ended in Mar. 2026 was ₹936.4 Mil. Therefore, Onyx Biotec's Asset Turnover for the quarter that ended in Mar. 2026 was 0.37.

Asset Turnover is linked to ROE % through Du Pont Formula. Onyx Biotec's annualized ROE % for the quarter that ended in Mar. 2026 was 2.49%. It is also linked to ROA % through Du Pont Formula. Onyx Biotec's annualized ROA % for the quarter that ended in Mar. 2026 was 1.47%.

Onyx Biotec  (NSE:ONYX) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Onyx Biotec's annulized ROE % for the quarter that ended in Mar. 2026 is

ROE %**(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=13.72/550.6485
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(13.72 / 697.688)*(697.688 / 936.394)*(936.394/ 550.6485)
=Net Margin %*Asset Turnover*Equity Multiplier
=1.97 %*0.7451*1.7005
=ROA %*Equity Multiplier
=1.47 %*1.7005
=2.49 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Onyx Biotec's annulized ROA % for the quarter that ended in Mar. 2026 is

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=13.72/936.394
=(Net Income / Revenue)*(Revenue / Total Assets)
=(13.72 / 697.688)*(697.688 / 936.394)
=Net Margin %*Asset Turnover
=1.97 %*0.7451
=1.47 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Onyx Biotec Asset Turnover Related Terms

Onyx Biotec Asset Turnover Historical Data

* Premium members only.

The historical data trend for Onyx Biotec's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Biotec Asset Turnover Chart

Onyx Biotec Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Asset Turnover
1.22 0.83 0.81 0.75 0.75

Onyx Biotec Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Asset Turnover Get a 7-Day Free Trial 0.00 0.41 0.35 0.38 0.37

NSE:ONYX vs ISRG, BDX, MDLN: Asset Turnover Comparison

For the Medical Instruments & Supplies subindustry, Onyx Biotec's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Onyx Biotec Asset Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Onyx Biotec's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Onyx Biotec's Asset Turnover falls into.


NSE:ONYX
13GF Score
Onyx Biotec Ltd NSE:ONYX
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Biotec Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Onyx Biotec's Asset Turnover for the fiscal year that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2026 )/( (Total Assets (A: Mar. 2025 )+Total Assets (A: Mar. 2026 ))/ count )
=694.694/( (912.479+951.546)/ 2 )
=694.694/932.0125
=0.75

Onyx Biotec's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=348.844/( (921.242+951.546)/ 2 )
=348.844/936.394
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.37 mean?
Onyx Biotec (NSE:ONYX) has a Asset Turnover of 0.37 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Onyx Biotec and its competitors.
Is Onyx Biotec's Asset Turnover too high?
Onyx Biotec's current Asset Turnover is 0.37. Overall, Onyx Biotec has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's Asset Turnover compare to ISRG and BDX?
Onyx Biotec's Asset Turnover of 0.37 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Medical Devices & Instruments company?
A good Asset Turnover depends on the Medical Devices & Instruments industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Onyx Biotec and its competitors. Onyx Biotec's current Asset Turnover is 0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current Asset Turnover of 0.37. The current Asset Turnover is 0.37. Onyx Biotec's overall GF Score™ is 13/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current Asset Turnover is 0.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onyx Biotec Business Description

Address Nalagarh Road, Near Sainimajraropar, Village Bir Plassi, Solan, HP, IND, 174101
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
13GF Score

Get the complete analysis for NSE:ONYX

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹41.50
Price